Vaxcyte, Inc. · NASDAQ:PCVX
Cowan Elvia sold 3,000 Vaxcyte, Inc. shares (Form 4)
Traded Nov 2, 2026 · Filed Nov 4, 2026
On Nov 2, 2026, Cowan Elvia (SVP, Finance & CAO) sold 3,000 Vaxcyte, Inc. shares at an average US$60.92 for US$183K under a trading plan, leaving 27,860 shares. Filed Nov 4, 2026 (Form 4).
- Sold
- 3,000 shares
- Price
- US$60.92 average (US$60.77 to US$61.55)
- Value
- US$183K
- Holding after
- 27,860 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, Finance & CAO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Common Stock | Option exercise | 3,000 | US$25.92 | 30,860 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 2,414 | US$60.77 | 28,446 | Direct |
| Nov 2, 2026 | Common Stock | Sale | 586 | US$61.55 | 27,860 | Direct |
Source
Download original · View original at SEC
Related
- Vaxcyte, Inc.
- Cowan Elvia
- Vaxcyte, Inc. shareholders
- Form 4 · Cowan Elvia · Oct 7, 2026
- Form 4 · Cowan Elvia · Sep 9, 2026
- Form 4 · Cowan Elvia · Sep 2, 2026
- Form 4 · Cowan Elvia · Apr 8, 2026
- Schedule 13G · Wellington Management Group LLP · Nov 16, 2026
- Form 4 · Dhaliwal Harpreet S. · Nov 13, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Nov 6, 2026
- Form 4 · Wassil Jim · Nov 4, 2026